로딩 중…
지수 로딩 중…
Arcturus Therapeutics Holdings Inc.
ARCT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$6.00+4.17%
2026-08-03
Financials
Valuation Metrics
Arcturus Therapeutics Holdings Inc.'s Market Cap is $171M. At end of 2025 it was $168M. Ranked #3044 of 3,112 in US market (top 98%), #1387 of 1,445 on NASDAQ (top 96%), #256 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 95%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $171M | US#3,044/3,112 Sec#256/269 |
| Revenue | $45M | US#2,867/3,112 Sec#159/269 |
| Net Income | $-79M | US—/3,112 Sec—/269 |
| Total Assets | $245M | US#2,947/3,112 Sec#237/269 |
| Net Assets | $191M | US#2,746/3,112 Sec#200/269 |
| Value | ||
| P/B | 0.89x | US#270/3,112 Sec#12/269 |
| P/S | 3.76x | US#2,020/3,112 Sec#60/269 |
| FCF Yield | -34.53% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -41.11% | US#2,698/3,112 Sec#154/269 |
| ROA | -32.06% | US#2,883/3,112 Sec#167/269 |
| Op. Margin | -196.72% | US#2,857/3,112 Sec#135/269 |
| Revenue Growth | -97.92% | US#2,942/3,112 Sec#188/269 |
| Financial Health | ||
| Debt Ratio | 28.24% | US#303/3,112 Sec#99/269 |
| Total Debt | $24M | US#2,671/3,112 Sec#174/269 |
| FCF | $-59M | US#2,491/3,112 Sec#120/269 |
| Cash | $211M | US#1,680/3,112 Sec#109/269 |
| Current Ratio | 6.31x | US#380/3,112 Sec#124/269 |
| Performance | ||
| 1Y Return | -51.22% | US#2,984/3,112 Sec#247/269 |
| 1M Return | -17.58% | US#2,897/3,112 Sec#225/269 |
| From 52W High | -75.18% | US#3,060/3,112 Sec#261/269 |
| 1Y MDD | -76.12% | US#3,016/3,112 Sec#254/269 |
| Trading | ||
| Volume | 249,607 shares | US#2,527/3,112 Sec#244/269 |
| Trading Value | $1M | US#2,985/3,112 Sec#251/269 |
| Per Share | ||
| EPS | $-2.40 | US—/3,112 Sec—/269 |
| BPS | $7.81 | US#1,956/3,112 Sec#88/269 |